PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-53.88%
Negative revenue growth while ANO.AX stands at 62.13%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.32%
Negative gross profit growth while ANO.AX is at 251.94%. Joel Greenblatt would examine cost competitiveness or demand decline.
118.21%
EBIT growth 75-90% of ANO.AX's 155.25%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
118.21%
Operating income growth under 50% of ANO.AX's 648.74%. Michael Burry would be concerned about deeper cost or sales issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.49%
Share count expansion well above ANO.AX's 0.62%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
60.93%
Diluted share count expanding well above ANO.AX's 0.46%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
130.13%
Positive OCF growth while ANO.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-46.67%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
188.14%
10Y revenue/share CAGR at 75-90% of ANO.AX's 223.10%. Bill Ackman would press for new markets or product lines to narrow the gap.
4125.22%
Positive 5Y CAGR while ANO.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
129.75%
10Y OCF/share CAGR above 1.5x ANO.AX's 77.99%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
148.45%
Positive OCF/share growth while ANO.AX is negative. John Neff might see a comparative advantage in operational cash viability.
No Data
No Data available this quarter, please select a different quarter.
-5.76%
Negative 10Y net income/share CAGR while ANO.AX is at 4293.06%. Joel Greenblatt sees a major red flag in long-term profit erosion.
No Data
No Data available this quarter, please select a different quarter.
141.41%
Positive short-term CAGR while ANO.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
382.46%
We increase R&D while ANO.AX cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
89.07%
SG&A growth well above ANO.AX's 14.86%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.